This brand name is authorized in Estonia, Lithuania
The drug AIRCOSONA contains one active pharmaceutical ingredient (API):
|
1
Eformoterol
UNII 5ZZ84GCW8B - FORMOTEROL
|
|
Formoterol is a predominantly selective β2-stimulator. Formoterol has bronchodilator activity in patients with reversible obstructive airway diseases. In humans formoterol is effective in the prophylaxis of bronchospasm induced by methacholine challenge. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| R03AC13 | Formoterol | R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AC Selective beta-2-adrenoreceptor agonists |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1631854, 1631865, 1631876, 1631887, 1631898 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1071896, 1071897, 1076864, 1076865, 1076866, 1076867, 1076868, 1076869 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
